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Amplify antimicrobial photo 
dynamic therapy efficacy 
with poly‑beta‑amino esters 
(PBAEs)
Stefano Perni, Emily C. Preedy & Polina Prokopovich* 
Light‑activated antimicrobial agents (photosensitisers) are promising alternatives to antibiotics for 
the treatment of skin infections and wounds through antimicrobial photo dynamic therapy (aPDT); 
utilisation of this technique is still restricted by general low efficacy requiring long exposure time (in 
the order of tens of minutes) that make the treatment very resource intensive. We report for the first 
time the possibility of harvesting the cell penetrating properties of poly‑beta‑amino esters (PBAEs) 
in combination with toluidine blue O (TBO) to shorten aPDT exposure time. Candidates capable of 
inactivation rates 30 times quicker than pure TBO were discovered and further improvements through 
PBAE backbone optimisation could be foreseen. Efficacy of the complexes was PBAE‑dependent 
on a combination of TBO uptake and a newly discovered and unexpected role of PBAEs on reactive 
species production. Chemometric approach of partial least square regression was employed to assess 
the critical PBAE properties involved in this newly observed phenomenon in order to elicit a possible 
mechanism. The superior antimicrobial performance of this new approach benefits from the use of well 
established, low‑cost and safe dye (TBO) coupled with inexpensive, widely tested and biodegradable 
polymers also known to be safe. Moreover, no adverse cytotoxic effects of the PBAEs adjuvated TBO 
delivery have been observed on a skin cells in vitro model demonstrating the safety profile of this new 
technology.
Skin and soft-tissue infections (SSTIs) are some of the most common infections observed in ambulatory practice 
and hospitals; to further concern, their rate has increased in the last  decades1. SSTI symptoms range from mild 
conditions, such as pyoderma, to serious life-threatening such as necrotizing fasciitis; besides the affected area 
(i.e. hands or legs) may lose functionality depending on the severity of the  infection2. Clearly SSTI are simultane-
ously a threat to life and quality of life to patients and an economic burden to health care  providers3,4; i.e. it has 
been estimated that every MRSA infection costs an extra 9000 £ to the  NHS5 while in the USA the total spent 
on the treatment of SSTIs tripled between 2000 and 2012, from $4.4 to $13.8  billion6.
Antibiotics are the first line approach to treat SSTI, however their efficacy is rapidly decreasing in consequence 
of the growth of antibiotic resistance among pathogens. New antibiotics, such as oritavancin or delafloxacin, to 
treat SSTI, have  emerged7,8; nonetheless it is expected that antibiotic resistance will outpace the development of 
new drug thus different antimicrobial treatment is urgently needed.
Photodynamic therapy is a local, repeatable non-invasive technique which might be an effective alternative 
to antibiotics for the treatment of local  infections9,  periodontitis10 and diabetic foot  ulcer11,12. The mechanism 
of action of PDT derives from a light-induced excitation of a photosensitiser (PS) to singlet state and its conver-
sion to triplet state, whose reactivity results in the generation of radicals and  ROS13,14. These cell death inducing 
capabilities of ROS have found medical applications in  cancer15 and infections (antimicrobial-PDT or aPDT) 
 treatment14.
aPDT feasibility depends on the higher resistance of mammalian cells than pathogens to the oxidation 
induced by light activated  compounds16,17 and by biologically compatible light activated compounds  PS13,14. 
Lethality mechanism of aPDT is multi-targets; hence it is not prone to induce further  resistance14,18–20. A further 
benefit of aPDT is the possibility of inactivating not only viable cells but also virulence factors released by patho-
gens that can cause tissue damage after bacterial  death21. This possibility makes aPDT stand alone in the variety 
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of antimicrobial techniques that are capable of only interacting with cells leaving virulence factors untouched. 
Clinical trials have also investigated aPDT for the treatment of skin  infections22–25.
Despite the numerous mentioned benefits of aPDT, the necessary exposure time (in the order of 10–15 min)26 
is currently the main obstacle to its application in hospital settings as this limits the number of patients that can be 
treated per beds available. The challenge of reducing the irradiation time necessary to achieve aPDT satisfactory 
results has been addressed by developing delivery systems that augment PS  uptake27,28 or designing novel PS that 
either exhibit selective affinity to bacterial cells over other tissue cells or are more potent ROS  producers11,29–31. 
Despite the positive results, such advances are not yet sufficient in terms of efficacy or economically viable; con-
sequently, new approaches are required in order to tackle the antibiotic resistance threat in a cost-effective way 
that maximises the return of health providers scarce resources.
Poly-beta-amino esters (PBAEs) were first described as biodegradable and biocompatible polymers with cell 
membrane penetrating characteristics that could be employed as gene transfer vectors in light of their positive 
charges and ability to form complexes with DNA  molecules32. We hypothesised that PBAEs capabilities to actively 
deliver molecules inside cells could be exploited as adjuvant to microbial cell uptake of toluidine blue O (TBO) 
and demonstrated for the first time that PBAE-TBO complexes can have higher antimicrobial activity after laser 
exposure than the comparable amount of free dye on various pathogens representative of SSTI (Fig. 1). TBO was 
chosen in light of being one of the few light activated compounds already approved for clinical  use14. We then 
investigated a library of PBAEs to judge whether optimisation was feasible and identified candidates capable 
of increasing inactivation rates to > 30 times than those of pure TBO. This has the potential of providing the 
long-awaited break-through that could have clinical relevance in the treatment of SSTI. We also ascertained key 
PBAEs features that would allow further targeted development through data analytics algorithms. Finally, the 
effect on skin cells (keratinocytes and fibroblasts) was assessed in vitro to supplement the antimicrobial efficacy 
data of the technology with clear safety results.
Materials and methods
Synthesis of PBAEs. Acrylate-terminated poly(β-amino ester)s were synthesized by mixing 1,4-butandi-
ole diacrylate, 1,6-hexanediol diacrylate or tetra(ethylene glycol) diacrylate with a range of amine monomers 
(Fig. 2) in dichloro-methane (DCM) with a acrylate  excess33,34. The polymerisation, a Michael addition reaction 
(Fig. 3), was performed under stirring at 50 °C for 48 h. PBAEs were precipitated through pouring the reaction 
mixture in about 10 times the volume of diethyl-ether under vigorous mixing; the solvent was then removed 
under vacuum.
Acrylate-terminated polymers of were dissolved in DCM at a concentration of 31.13% w/w. A range of 
end capping agents (Fig. 2) were then  added33,34. End-capped PBAEs were recovered through precipitation in 
diethyl-ether under vigorous mixing, the unreacted amines were removed centrifuging the suspension of PBAE 
in diethyl-ether/DCM for 2 min at 1155g. The supernatant was removed and the PBAEs washed twice with 
diethyl-ether. The end-capped PBAEs were then dried under vacuum.
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The PBAEs and derivatives obtained were coded through the constituents of the backbone using a capital letter 
to indicate the acrylate (e.g. A being 1,4-butanediol acrylate) and a number to indicate the amine as shown in 
Fig. 2; the further end-capping is describes by a number preceded by the letter e. For example, A2-e1 is the PBAE 
obtained from 1,4-butanediol diacrylate and 4,4′-Trimethylenedipiperidine then capped with ethylene-diamine.
PBAE characterization. Gel permeation chromatography (GPC) was employed to determine the molecu-
lar weight of each PBAE in the library. Samples were injected in a Shimadzu-LC-20Ai system equipped with a 
Superdex 75 10/300 GL column; the mobile phase was 100% sodium acetate buffer pH = 5 at a constant flow of 
1 mL/min. Number-averaged (Mn) and weight-averaged molecular weight (Mw) were determined against PEG 
standards. Molar masses were only apparent values due to the use of PEG standards and possible different hydro-
dynamic volumes of PEG standards and poly(beta-amino esters) of identical molar  mass34.
Preparation of TBO–PBAEs complex. 10  mg of TBO were dissolved in DCM (25  mL) along with 
100 mg of end-capped polymer; the solutions were immediately covered with aluminium foil and stirred for 
24 h at room temperature. The PBAEs-TBO derivatives were recovered through precipitation in diethyl-ether 
under vigorous mixing, the unreacted molecules were removed centrifuging the suspension of PBAE in diethyl-
ether/DCM for 2 min at 1155g. The supernatant was removed and the PBAEs washed twice with a diethyl-ether/
DCM mixture 4:1. The end-capped PBAEs were then dried under vacuum and appeared viscous fluids at room 
temperature.
PBAE are known to form micelles when in aqueous  fluids33,35, we hypothesized that the PBAEs-TBO com-
plexes would be constituted by micelles containing TBO with PBAEs on the outer shell.
Antimicrobial protocol. The organisms used in this study were representatives of pathogens encoun-
tered in SSTI. Escherichia coli (NCTC10418), Staphylococcus epidermidis  (ATCC12228), Pseudomonas aer-
uginosa (NCIMB10548), Methicillin Resistant Staphylococcus aureus (NCTC12493), Streptococcus pyogenes 
(ATCC19615) and Acinetobacter baumannii (NCIMB9214) were stored at − 80 °C. These organisms were sub-
cultured, when needed, on Brain Heart Infusion (BHI) Agar overnight aerobically at 37 °C. The plates were then 
stored at 4 °C for no more than two weeks. Bacterial suspensions used for the experiments were grown in Brain 
Heart Infusion (BHI) broth after inoculation with a loopful of cells from a single colony on a BHI plate and 
incubated aerobically for 24 h at 37 °C statically. These overnight cultures were then diluted 1 in 100 in PBS. The 
resulting bacterial suspension contained approximately  106 CFU/mL. Each cell suspension was used to disperse 
pure TBO to concentrations of 0.2 mg/mL or PBAEs-TBO derivatives to an equivalent TBO concentration.
200 μL aliquots of the resulting suspension were immediately poured in a GREINER 96 U-BOTTOM 
well plate. The well plate was then irradiated with a laser light (633 nm) using a 500 mW red laser (RRL-
635 nm-500 nm-1080060, Changchun New Industries Optoelectronics, China) for different time periods 
(between 10 s to 3 min).
After exposure the bacterial cells (L+S+) were counted through serial dilutions and plating on BHI Agar. 
Along this test, different experiments were performed including the testing of dark toxicity (labelled with L−S+), 
samples exposed uniquely to laser light (L+S−) or samples not exposed to either laser light or PBAE (L−S−).
Figure 2.  Structure and coding of constituents of PBAEs library used.
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Through the experiments, all prepared samples, well plates and inoculated plates were immediately covered 
with aluminium foil to reduce biased measuring results due to exposure of any light besides the laser. All plates 
were incubated after the experiment for 24 h at 37 °C prior to colony forming units counting. All experiments 
were performed on three independent cultures.
Spectroscopy. UV–Vis spectrum was determined using the Cary 60 UV–Vis Spectrophotometer (Agilent 
Technologies, United States).
Absorption of pure TBO and produced TBO–polymers complexes were measured using standard cuvettes. 
All samples were diluted in PBS to concentrations of equivalent to 20 μg/mL of pure TBO.
Reactive singlet oxygen species. The generation of reactive oxygen species (ROS) was assessed using a 
singlet oxygen Sensor Green reagent (SOSG) (Molecular Probes, Unites States). The SOSG was stored at ≤ − 20 °C 
and protected from light prior to use. The working solution was prepared with methanol to a final concentration 
of 5 mM. The prepared reagent was further diluted in methanol (1:100) before each experiment. Each sample 
was dispersed in PBS to a concentration equivalent to 0.2 mg/mL of pure TBO. 100 μL of diluted sample, 100 μL 
PBS and 20 μL reagent were immediately poured in two adjoining wells of a GREINER 96 U-BOTTOM well 
Figure 3.  (a) PBAE structure and synthesis (b) PBAE-TBO micelles.
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plate. The irradiation of one well (L+) was in each case carried out for a period of 1 min with a 500 mW red laser 
(RRL-635 nm-500 nm-1080060, Changchun New Industries Optoelectronics, China); whilst the other well was 
covered with aluminium foil (L−). After exposure, ROS were determined using the FLUOstar OPTIMA (BMG 
Lab technologies, Germany).
TBO uptake in bacterial cells. 10 mL of fresh sterile BHI broth were inoculated with a loopful of cells 
from a single colony on a BHI plate and incubated aerobically for 24 h at 37 °C statically. The bacterial suspen-
sion was then centrifuged with an Avanti J-20XP Centrifuge (Beckmann and Coulter, United States) for duration 
of 3 min at 2938g, afterwards the supernatant was disposed. After one wash and centrifuge with PBS, 1 mL of 
sample (equivalent concentration of pure TBO of 0.2 mg/mL) was added to the precipitated cells. The resulting 
solution was vortexed and centrifuged after 3 min exposure. The exposure of samples to cells was limited to 
3 min to ensure comparability to other experiments. After two more wash- and centrifugation cycles with PBS, 
the cells were dissolved in 1 mL 0.1 M NaOH/1% sodium dodecyl sulphate (SDS) and incubated at 37 °C for 
24 h to lysate the cells.
The optical density of samples was measured at a 650 nm using a plate reader (Labtech LT5000MS) against 
a calibration curve prepared using the corresponding bacterial lysate.
Data analysis. Hieratical clustering (using Manhattan distance between PBAEs and complete distance 
between clusters) was performed R (ver 4.0) and the “stats”  package36. Partial Least Square (PLS) regression 
analysis between PBAEs characteristics and ROS production ratio between PBAE-TBO complexes and pure 
TBO was carried out using R (ver 4.0)36 and the “plsdepot”  package37.
The physical and chemical parameters of each PBAE constituents (amines and acrylates) were obtained 
from PubChem library (logP, TPSA, Complexity, Heavy Atom Count, Volume 3D, X_Steric Quadrupole 3D, 
Y_Steric Quadrupole 3D, Z_Steric Quadrupole 3D) while the parameters related to the basic repeated polymeric 
unit (amine + acrylate) were calculated through ChemDraw. These included molecular weight (MW), boiling 
point (BP); melting point (MP); critical volume (CV), Gibb’s free energy (GFE), logP, solubility (logS), pKA, 
molar refractivity (CMR), heat of formation (HtF), TPSA and the ratio between the MW of amine and acrylate. 
TPSA (topological polar surface area) represents the total area of all polar atoms (mainly oxygen and nitrogen) 
including their affixed hydrogen atoms while logP is the partition-coefficient between two immiscible phases 
at equilibrium which is proportional to hydrophobicity of the compound of  interest34. Further experimentally 
determined properties of the PBAEs (Mw, Mn and zeta potential) were also added to the properties of PBAE 
included in the PLS regression.
The minimum number of PLS components to describe the role of different PBAEs chemical–physical proper-
ties on the ROS production was determined as the minimum number of PLS components that return at least 80% 
of the initial input data and an inflection in the scree plot representing the root mean squared error (RMSE) of 
the predictions vs. number of PLS components  was38,39.
In vitro safety assessment. Cells culture. Human keratinocytes cells (ATCC PCS-200-011) were grown 
in Dermal Cell Basal Medium supplemented with Keratinocyte Growth Kit (ATCC); whilst human dermal fi-
broblast cells were kindly supplied by Prof.  Stephens40 from Cardiff University and grown in Minimum Essential 
Medium Eagle (MEM) supplemented with 10% heat-inactivated foetal bovine serum (FBS). Both media were 
supplemented with 1% penicillin–streptomycin (PS). Both cells lines were incubated at 37 °C in a humidified air 
atmosphere with 5%  CO2; media were changed twice per week. 96 well plates were seed with 150 μL containing 
10,000 viable cells as determined through trypan blue staining and incubated for 5 days at 37 °C in a humidified 
air atmosphere with 5%  CO2; media were changed after 2 days.
PDT exposure. Cells were washed three times with PBS and incubated with 100 μL of either TBO 0.2 mg/mL 
or TBO–PBAE containing TBO 0.2 mg/mL After 2 h, wells were washed once with 100 µL of treatment media 
and maintained in this media thereafter. The well plate was then irradiated with a laser light (633 nm) using a 500 
mW red laser (RRL-635 nm-500 nm-1080060, Changchun New Industries Optoelectronics, China) for 3 min.
Control experiments included testing of dark toxicity (labelled with L−S+), samples not exposed to TBO and 
uniquely to laser light (L+S−) or samples not exposed to either laser light or PBAE (L−S−).
Cytotoxicity assay. 20 μL of MTT stock solution (5 mg/mL) were added to each well and incubated in a humidi-
fied atmosphere at 37 °C with 5%  CO2. After 4 h, the supernatant was then removed and 100 μL of dimethyl 
sulfoxide were added. The absorbance was measured by a spectrophotometer (Lab Tech LT5000MS) at 560 nm; 
mitochondrial activity was normalised against cell exposed to fresh medium only.
LDH was quantified in the media (LDH released) and after adding the cell lysis solution (LDH total) accord-
ing to manufacturer’s protocols. Total and released LDH (indicated as  LDHtotal and  LDHreleased respectively) 
were determined as OD, at 490 nm, after correcting for the reading from the negative control. Cell viability was 
calculated according to the following equation:41
Statistical analysis. Differences among the different samples (L+S+, L−S+, L+S−, L−S−) in the MTT and 
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Multivariate analysis of variance (MANOVA) was carried out to test impact of the different end-capping 
agents on the antimicrobial activity, TBO cell up-take and ROS production of PBAE-TBO against pure TBO, 
using the Pillai test with a significant level p = 0.05.
Results
UV spectra. UV–vis spectra of pure TBO showed a maximum of absorbance at about 633 nm; spectra pro-
files did not vary when TBO was complexed with PBAE (Fig. 4).
Antimicrobial activity. In all six species tested (Fig. 5), viable bacteria decreased with the increase of irra-
diation time when in the presence of TBO (L+S+); inactivation rates due to irradiation and TBO were higher 
for three Gram+ pathogens employed (S. epidermidis, MRSA and S. pyogenes) than the Gram- (P. aeruginosa, E. 
coli and A. baumannii).
In all cases, samples exposed to the polymer-TBO complex or to pure TBO without irradiation (L−) did not 
return any cell reduction over the time considered. In comparison, irradiated (L+) samples show tendencies of 
progressive reduction. The comparison with pure TBO showed an obvious improvement in the antimicrobial 
effect of laser exposure in all cases when the same amount of photosensitiser was employed along with A3-e1. 
Furthermore, when cells were exposed to laser light without the presence of photosensitiser (L+S−) did not 
reveal any antimicrobial activity. Furthermore, PBAE alone (without TBO) did not exhibit antimicrobial activity 
towards any of the pathogens tested either in the dark or after laser irradiation.
PBAE optimisation. The comparison of the efficacy of other PBAE as delivery system of TBO for antimi-
crobial PDT against an example of Gram− (E. coli) and an example of Gram+ (S. epidermidis) is shown in Fig. 6. 
Clustering of the PBAE synthesised revealed that main difference among polymers was the acrylate component 
with Poly(ethylene glycol) diacrylate (acrylate C) forming a cluster more distant than 1,6-Hexanediol diacrylate 
(acrylate B) or 1,4-Butanediol diacrylate (acrylate A); the couples of amines 4,4′-Trimethylenedipiperidine 
(amine 2) and N,N-bis[(3-methylamino)propyl]methylamine (amine 20) along with 3-(dimethylamino)-1-pro-
pilamine (amine 5) and cyclopentylamine (amine 15) resulted in similar PBAE than any of the other amines.
Using similar amine and end-capping agent for the preparation of PBAE, 1,6-Hexanediol diacrylate (acrylate 
B) was usually more effective than 1,4-Butanediol diacrylate (acrylate A) with Poly(ethylene glycol) diacrylate 
(acrylate C) returning the worst antimicrobial activity of the three. Most of the PBAE-TBO complexes improve 
the antimicrobial activity compared to the same amount of pure TBO. PBAEs end-capped with e2 had better 
antimicrobial activity that the respective counter-part end-capped with e1 (p < 0.05).
Cell uptake. All PBAE tested increased the uptake of TBO in both E. coli and S. epidermidis (Fig. 7), polymer 
exhibiting 1,6-Hexanediol diacrylate in their backbone performed better than those with 1,4-Butanediol dia-
crylate in most of the cases and the adjuvant effect of PBAE is remarkably greater in S. epidermidis than in E. coli. 
Poly(ethylene glycol) diacrylate generally did not enhance TBO cell uptake. PBAEs end-capped with e2 resulted 
in higher TBO cellular uptake that the respective counter-part end-capped with e1 (p < 0.05).
Figure 4.  Example of UV spectra of TBO (dark green line) and PBAE-TBO (A3, orange line; B3, purple line; 
C3, pink line; and A5, light green line).
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Reactive oxygen species production. The amount of ROS generated by pure TBO only PBAE-TBO 
complexes is shown in Fig. 8 and reveals a strong dependence on the presence and structure of the PBAE. In 
most of the cases, TBO complexes with polymers prepared with 1,6-Hexanediol diacrylate performed better 
than those prepared with 1,4-Butanediol diacrylate. TBO in combination with complexes of PBAEs end-capped 
with e2 resulted in higher ROS that the respective counter-part end-capped with e1 (p < 0.05).
No ROS were detected when only PBAE were exposed to laser light, hence PBAE are not photosensitisers. 
This demonstrate that PBAE do not only act in enhancing TBO uptake by cells but also have a direct role in the 
mechanism of radicals formation by PDT.
Antimicrobial activity of PBAE-TBO complexes on either S. epidermidis or E. coli was not solely depended 
on TBO uptake but was a combination of both uptake and ROS as not linear correlation was noticeable (Fig. 9).
PBAEs feature selection in ROS production. PLS model predictions of ROS production against the 
experimental data improved with increasing number of PLS components as represented by the increasing MRSE 
and  R2 (Table S2 and Supplementary material). The scree plots exhibited an inflection at transition from 11 to 12 
PLS components (Supplementary material); therefore 11 PLS components were chosen to describe the variation 
within this dataset of PBAE-TBO complexes. The experimental data of ROS production by PBAE-TBO synthe-
sised were closely match by the predictions (Supplementary material); the residual did not reveal clear patterns 
(Supplementary material) and followed a normal distribution (Supplementary material).
For both end-capping agents, PBAE zeta potential was negatively correlated to the ROS production of the 
TBO–PBAE complexes after laser irradiation, on the contrary LogP and steric occupation (StericQuad3D) of 
the amine component of the polymer was positively correlated to ROS formation (Fig. 10).
Figure 5.  Antimicrobial activity of TBO (blue circles) and A3-e1-TBO (orange circles) against (a) E. coli, (b) P. 
aeruginosa, (c) A. baumannii, (d) MRSA, (e) S. epidermidis and (f) S. pyogenes (mean ± SD, n = 3).
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In vitro test on skin cells. Mitochondrial activity, estimated through MTT assay, and cell viability deter-
mined through LDH assay of both keratinocytes and fibroblasts were not impacted (p > 0.05) by exposure to a 
selection of the TBO–PBAE prepared, additionally not dark toxicity was detected in either cell lines (Fig. 11).
Figure 6.  Log10 reduction of viable cells after 30 s laser exposure of E. coli and S. epidermidis comparted to pure 
TBO when exposed to different TBO–PBAEs end-capped with (a) e1 and (b) e2.
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Discussion
aPDT has numerous benefits as potential alternative to antibiotics for the treatment of infections such as skin and 
tissues that can be accessed with light  sources10,12,42; however a critical drawback is the still relative long treatment 
time required (in the order of tens of minutes) that impacts the largescale application of this  technology26. The 
design of novel and more efficient photosensitisers is generally accompanied by elevated drug costs; similarly, 
the use of drug delivery systems brings additional costs that must be offset by the enhanced efficacy. We have 
Figure 7.  Uptake of TBO for E. coli and S. epidermidis comparted to pure TBO when exposed to different 
TBO–PBAEs end-capped with (a) e1 and (b) e2.
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brought a new approach to boost aPDT efficacy through the use of polymers enhancing intracellular drug uptake; 
our starting point was the use of a photosensitiser commercially available and approved for use in humans, 
specifically TBO (widely used, inexpensive and with a very well-known safety profile)43, and polymers proven 
biocompatible and low cost such as PBAE. The safety profile of the compounds used in this technology offers 
both a shorter route to market and a high likelihood of future in vivo trials of this approach to prove safety while 
the use of low-cost chemicals also improves opportunities to be cost-effective.
We firstly validated the hypothesis of using PBAE to augment PDT on a variety of pathogens representing 
those most commonly encountered in  SSTI44,45; subsequently the role of polymer backbone constituents was 
assessed through a broad library of PBAE and a new discovery, the impact on ROS, beside TBO uptake was 
also observed. PBAE features critical in this newly noticed phenomenon were assessed through PLS, one of 
chemometrics data analytic techniques that have been employed in drug design and analytical  chemistry34,46,47, 
Figure 8.  ROS produced by different PBAEs-TBO after 1 min irradiation compared to pure TBO.
Figure 9.  Correlation of ROS produced and TBO uptake on antimicrobial activity (ratio of log10 reduction 
after 30 s laser irradiation in the presence of TBO or PBAE-TBO) of E. coli (green circles) and S. epidermidis 
(orange circles) by different PBAEs-TBO.
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Figure 10.  PLS derived correlations for the different PBAEs characteristic (input parameters within the model) 
and ROS production for PBAE end-capped with e1 (a) and e2 (b).
Figure 11.  MTT and LDH on keratinocytes (green circles) and fibroblasts (orange circles) exposed to TBO and 
TBO–PBAEs (mean ± SD, n = 3).
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to also elicit possible mechanism. Initial in-vitro tests on keratinocytes cells and fibroblasts were also carried 
out exposing the cells to a selection of the PBAE-TBO complexes that exhibited the greatest enhancement of 
antimicrobial activity; in order to gather more robust safety data, two independent assays (MTT and LDH) were 
utilised with both showing the safety of the complexes PBAE-TBO on skin tissue cells.
The higher vulnerability of Gram+ over Gram− observed in this study (Fig. 5) was expected in line with 
several  studies48–50 and is widely considered to be explained by the relatively porous layer of peptidoglycan and 
lipoteichoic acid constituting the cell wall of Gram+ that allows the photosensitiser to cross the cell wall compared 
to the cell envelope of Gram- bacteria that exhibit higher resistance to photosensitiser  uptake48.
PBAE were first described as gene transfer  vectors32; subsequent evidence has validated such properties and 
identified key features and optimised the polymer chain backbone in order to maximise the opportunities offered 
by such polymers to transfer genes into target  cells35,51. Further applications of PBAEs have been proposed for 
cancer drug  delivery52–55, in layer-by-layer deposition of drug releasing  coatings41,56–61 and drug localisation 
in  cartilage33,34; currently no application of these polymers in antimicrobial technologies has been reported. 
Depending on the application, different PBAE features have been shown to pivot the outcome; for example 
PBAEs belonging to the family of B3 and A16 are known cell uptake enhancer in DNA  delivery32,35,51 while A5 
and B5 are better at driving drug uptake into  cartilage34; additionally it has also been proven that end-capping 
has a further critical  role34,35. Because of the essential role on TBO uptake into bacterial cells in controlling aPDT 
effect, it was not unexpected that polymer synthesised with acrylates such as A and B with amines such as 3 and 
16 had the greatest impact on TBO uptake (Fig. 7).
All three constituents of PBAEs, namely diacrylate, amine and end-capping, influence all the outcomes 
investigated here (Figs. 6, 7, 8) in agreement with previous results on the various applications of  PBAEs34,35. 
None of the tested PBAEs have antimicrobial activity when used alone; furthermore, the overall performance 
of PBAE-TBO in bacteria inactivation is the combination of two phenomena in which PBAEs are responsible 
(Fig. 9), one is the cell uptake and another, seen for the first time in this work, in the generation of ROS by an 
irradiated photosensitisers. Because of the high reactivity of the singlet state, most of the energy absorbed by PS 
is re-emitted without resulting in any ROS. As PBAEs do not exhibit photosensitiser properties as shown by the 
absence of ROS for pure PBAE irradiated and the UV spectra of TBO is unaffected by the complexation with 
PBAE (Fig. 4), in order to explain the increase ROS formation, we hypothesised that PBAE may impact the sta-
bility of the TBO single/triple states resulting in a more efficient conversion of the light energy into ROS instead 
of re-emission; this charge separation and recombination phenomenon would be similar to those observed in 
polymers capped with light absorbing  moieties62. Alternatively, PBAE may also interact in the mechanisms PS 
releases the absorbed energy from the light resulting in the formation of PBAE radicals with longer half-life 
that react with the bacterial cells wall causing the microorganism inactivation. The results of the PLS indicating 
that PBAE zeta potential is inversely correlated to the ROS production suggests that the electrostatic attraction 
between PBAE and TBO (positively charged) is necessary for the augmented ROS formation by TBO when in 
presence of PBAEs. Moreover, the high correlation between TSPA (the level of polar surface) characteristics of 
PBAE components further support this hypothesis; under this hypothesis, it was expected that the correlation 
between TPSA of acrylates and amine had opposite signs as amine have positive charges whilst acrylates only 
exhibit oxygen atoms that results in negative charges.
PBAEs are biodegradable, therefore, it is expected that storage of aqueous suspensions of PBAE-TBO would 
exhibit progressively diminishing improvements on aPDT. This obstacle could easily be overcome as we envisage 
the storage of the prepared PBAE-TBO dried in airtight containers with PBS added just before use.
The duration of the exposure time necessary to reach satisfactory antimicrobial effects is key in controlling 
the number of patients that can be treated given the available beds/treatment bays capacity; thus, increasing 
inactivation rates and, consequently, shortening treatment times, reduces the indirect costs of the treatment 
or the required investments to set-up facilities with a set turn-over of patients. Most of the technologies devel-
oped to enhance photosensitiser uptake rely on the conjugation of the light activated compound to a bacterial 
targeting  polymer63, antimicrobial  polypeptides64–66 or a bacterial wall disruption agent (i.e.  gentamicin67 or 
 vancomycin68–70). Another type of approach is the encapsulation of the photosensitiser in liposomes or micelle 
that drive the light activate compound inside the bacterial  cell28,71,72. Compared to these approaches, the simple 
use of PBAE complexation with TBO that we developed removes the need of the conjugation or the encapsula-
tion step thus reducing costs and maximising yield.
Conclusions
Antimicrobial PDT has the potential to replace antibiotics in the treatment of skin and tissue infections helping 
the fight against antibiotic resistance; current applications are still significantly restricted by long exposure time 
necessary.
We developed a new approach to improving aPDT efficacy thought the use of PBAE to improve bacterial 
uptake of photosensitisers resulting in shorter exposure times that, in turn, men higher treatment bays turno-
ver. Reducing treatment times means that more patients can be treated with the currently available resources 
maximising their return. Further benefits of this technology over the current treatments of chronic wounds 
including the use of Iodine (Povidone),  KMnO4, bleach or silver are the safety, low cost and biological toler-
ance (linked to the biological compatibility of the degradation products). Additionally, our technology has the 
advantage that the PBAE-TBO is already a gel and such its topical application is very easy and does not require 
further formulation into a gel.
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